| Albumin infusion is not beneficial in hypoalbuminemic end-stage cancer patients: A matched-pair analysis | Abdullah BÜYÜKÇELİK,AHMET DEMİRKAZIK,Bülent YALÇIN,Mutlu DOĞAN,Halil KAVGACI,Şahin ÇOBAN,Fikri İÇLİ | 213–219 |
| Incidence of non-neutropenic infection (NNI) in patients with follicular lymphoma and small lymphocytic lymphoma: The effects of rituximab therapy | Rezwan ISLAM,Mahbubur RAHMAN,M. Anwarul Huq MIAN,Hilmi EGE,Douglas REDING,Md Abdus SHAKOOR,Hong LIANG,Richard MERCIER | 220–226 |
| Characteristics and outcomes of patients with primary central nervous system lymphoma: A single center experience and review of the literature | Serdal KORKMAZ,MEHMET ŞENCAN,ÜNAL ÖZÜM,Özen KARAADAĞ | 227–232 |
| Utility of “Over D1” or D1 nodal dissections in predicting outcome of patients with gastric adenocarcinoma treated with postoperative concurrent cchemoradiotherapy | UĞUR SELEK,ABDULLAH FARUK ZORLU,Gökhan ÖZYİĞİT,PERVİN HÜRMÜZ,Şuayib YALÇIN,Mustafa CENGİZ | 233–238 |
| Seroprevalence of HTLV I-II, HIV and HCV antibodies in lymphoma, head and neck cancer patients | Nuray BÜYÜKBERBER,KEZBAN TÜLAY YALÇINKAYA,Ramazan YILDIZ,Uğur COŞKUN,Mustafa BENEKLİ | 239–244 |
| Radiation therapy for early glottic carcinoma: factors influencing the outcome | CANDAN DEMİRÖZ ABAKAY,Lütfi ÖZKAN,Ümit GÜRLEK | 245–254 |
| Stereotactic radiosurgery in pituitary adenomas: A single center experience | Serdar SÜRENKÖK,ÖMER SAĞER,FERRAT DİNÇOĞLAN,Hakan GAMSIZ,Selçuka DEMİRAL,Bora UYSAL,Sait ŞİRİN,Kaan OYSUL,MEHMET MURAT BEYZADEOĞLU | 255–260 |
| Evaluation of late radiation side effects in nasopharyngeal cancer patients | ALPASLAN MAYADAĞLI,GÖKHAN YAPRAK,YILMAZ TEZCAN | 261–266 |
| A placebo-controlled, randomized, double-blinded, cross-over phase-I clinical study indicating the safety of topical ankaferd hemostat in healthy volunteers | Özlem Ş. BALÇIK,Mustafa KÖROĞLU,Handan CİPİL,Osman KAFTAN,Senem MARAl,Ayşe GÜREL,Hakan GÖKER,İbrahim C. HAZNEDAROĞLU,Ali KOŞAR | 267–274 |
| Histopathological alterations in the kidney tissue following topical ankaferd hemostat application in a rat renal injury model |